Editorial | an antibody patent released in deep The combined force of technology to fight off viruses is getting stronger and stronger

According to the Shenzhen Special Economic Zone News, recently, an anti-new coronavirus antibody was launched in Shenzhen, and the virus suppression rate was verified by the double P3 laboratory to exceed 99%.

It is reported that one of the characteristics of the anti-new coronavirus IgY antibody technology released this time is to extract and obtain specific anti-new coronavirus antibodies from the yolk of the immune hen, which completely avoids the cross-reaction of virus and complement in the human serum, and can specifically bind to the virus to produce an inhibitory effect on the virus.

In addition to the effective new crown virus inhibition rate, the anti-new crown virus IgY antibody also has the advantages of non-toxic, harmless, non-irritating natural antibodies, will not bring irritation and toxic side effects to the human body, can directly act on the surface of the skin and mucous membranes (mouth, nasal cavity), or the surface of the object, play an in vitro inhibition of the new crown virus; a single use, the inhibition of the new crown virus can be up to 3 hours, can provide users with effective in vitro virus defense.

This also means that people will get more effective epidemic prevention daily necessities, and on the basis of nucleic acid testing and vaccination, they will further transform into active epidemic prevention.

At a time when the new crown epidemic is still rampant, for people, the "anti-new crown virus IgY antibody" is undoubtedly a good news. Its advent is also a witness to the rapid development of Shenzhen's biological and life and health industries.

In May last year, the mainland's "new crown vaccine family" ushered in a new member - Kangtai Biological New Crown Vaccine. This is a COVID-19 vaccine produced in Shenzhen and the first COVID-19 vaccine approved for emergency use in Guangdong Province. Kangtai Bio's inactivated COVID-19 vaccine started research and development in February 2020, and in the phase I and II clinical trial data released in April last year, it showed that no adverse events of grade 3 or above occurred, and it obtained the national emergency use authorization license in early May last year and has fully started production.

Yes, defeating the epidemic ultimately requires the power of science and technology. As a high-tech developed city, Shenzhen's combination of science and technology epidemic prevention has played a great role, and the results are obvious to all. In particular, Shenzhen is committed to building a world-renowned biotechnology innovation center and biomedical industry agglomeration, over the years, Shenzhen has increased relevant support, in the policy, capital, projects, talents and other aspects of a number of measures, for Shenzhen's economic growth to add new impetus, new staying power.

At present, the Aomi Kerong is still spreading wildly, the number of confirmed cases around the world has surged, and many places in the mainland have also reported cases of Infection of the Aomi Kerong variant. However, with the continuous advancement of related technologies, the dawn of mankind's victory over the epidemic has been initially revealed.

According to media reports, Paxlovid, a new coronavirus treatment drug produced by Pfizer in the United States, was approved by Health Canada on the 17th, becoming the first oral drug approved to be used in Canada to treat new coronavirus infection. In addition, VV116, the only small molecule drug approved to enter clinical trials in China, will start the listing (NDA) application as soon as it passes the clinical trial within this year.

Zhang Wenhong said that vaccines and drugs will be the core scientific and technological support for us to survive the pandemic and return to normal life in the future, and China's scientific and technological forces, like the epidemic prevention troops, have been making unremitting efforts to smoothly survive the pandemic and save our people from the fear of infectious diseases.

Among them, Shenzhen is undoubtedly an important scientific and technological epidemic prevention force. Whether it is the new crown vaccine produced in Shenzhen or the "anti-new crown virus IgY antibody" in Shenzhen, it has made people see the hard-core scientific and technological strength of Shenzhen in this anti-epidemic war and see the responsibility of the city. Such a force will be integrated into the scientific and technological synergy of mankind to fight the epidemic, which will help mankind bid farewell to the new crown virus as soon as possible and return to normal life.